YMAB (YmAbs) Yalpi rentabellik

Y-mAbs Therapeutics Inc (YMAB) korporativ emblemasi va logotipi

Y-mAbs Therapeutics formula sintezi va sinovlarini tashqi pudratchilarga topshirgan holda, ilmiy markaz bo'lib qolmoqda. Valo profitability ushbu modelning samaradorligini tasdiqlaydi, bunda 81.70 so'nggi metrika qiymatini aks ettiradi. Daromadlar Danyelza savdosi va yuqori foyda marjalariga asoslangan. Muvaffaqiyatning muhim omili dori vositasining parchalanishini oldini olish uchun izotoplarni havo yo'llari orqali tezkor yetkazib berish bo'lib qolmoqda.

YMAB ymabs.com Yalpi foyda bo'yicha rentabellik (04.07.2022 - 27.09.2025)

Y-mAbs Therapeutics (YMAB) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Fundamental baholash:YMAB Y-mAbs Therapeutics Inc
Y-mAbs Corp yetakchi tovari

Bozor Y-mAbs Therapeutics (YMAB) kompaniyasini noyob miya o'smiklari terapiyasi sohasidagi monopol pozitsiyasi prizmasidan baholaydi, bu yerda dori vositalarining noyobligi raqobatchilar tomonidan narxlarga bo'lgan bosimni minimallashtiradi. Daromadning ulushi sifatida yalpi foydani tahlil qilish orqali investor bevosita ishlab chiqarish xarajatlarini qoplashdan keyin qolgan mablag'larni ko'rishi mumkin, bu esa biznesning erkin pul oqimini yaratish qobiliyatini belgilaydi va kompaniyaning uzoq muddatli moliyaviy barqarorligini tasdiqlaydi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|AURA - Yalpi foyda bo'yicha sotuv rentabelligi|CADL (Candel Therapeutics Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi ARAY (Accuray)|Yalpi foyda bo'yicha rentabellik SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Yalpi foyda marjasi|Yalpi rentabellik Citius Oncology, Inc. CTOR|HURA - Yalpi foyda bo'yicha rentabellik|protaratx.com - Yalpi marja|FATE - Yalpi marja|WHWK: Yalpi marja|TScan Therapeutics (TCRX) - Yalpi marja|Yalpi rentabellik Champions Oncology|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik